Genzyme Websites
Genzyme Business Sites
 | Genzyme Biosurgery
Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products, including Carticel ® and Synvisc ®.
|
| Genzyme Diagnostics
Genzyme Diagnostics offers a unique product portfolio for diagnostic manufacturers and clinical laboratories worldwide, with three key product areas: clinical chemistry, rapid tests and point of care diagnostics.
|
| Genzyme Oncology
Genzyme Oncology is focused on developing and commercializing novel treatments for cancer patients. It has a full pipeline and two marketed therapeutics: Campath ® and Clolar ®.
|
| Genzyme Pharmaceuticals
Genzyme Pharmaceuticals develops and manufactures specialty pharmaceutical/drug materials and value added technologies, products and services with an immediate focus in the lipid, peptide, amino acid derivatives and drug delivery markets.
|
| Genzyme Renal
Genzyme Renal is focused on improving the care of chronic kidney disease patients, with three marketed products – Renagel ®, Renvela ® and Hectorol ® – and a variety of programs and services. |
Genzyme Joint Venture Site
| MG Biotherapeutics
MG Biotherapeutics is a Medtronic-Genzyme joint venture to develop cell therapy solutions for unmet medical needs in cardiovascular disease through the combination of biologics and delivery devices. |
Genzyme Product Sites for US Audiences
| Aldurazyme®
Aldurazyme (laronidase) is an enzyme replacement therapy for mucopolysaccharidosis I (MPS I).
|
| Campath®
Campath (alemtuzumab for injection) is indicated for the treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and have failed fludarabine therapy.
|
| Carticel®
Carticel (autologous cultured chondrocytes) employs a unique process to grow a patient’s own cartilage cells for implantation to correct certain types of knee cartilage damage.
|
| Cerezyme®
Cerezyme (imiglucerase for injection) is an enzyme replacement therapy for Type 1 Gaucher disease.
|
| Clolar®
Clolar (clofarabine) is indicated for the treatment of children with refractory or relapsed acute lymphoblastic leukemia (ALL).
|
| Epicel®
Epicel (cultured epidermal autografts) is a permanent skin replacement product that is available for patients with life-threatening burns.
|
| Fabrazyme®
Fabrazyme (agalsidase beta) is an enzyme replacement therapy for Fabry disease.
|
| Hectorol®
Hectorol (doxercalciferol) is indicated for the treatment of secondary hyperparathyroidism in patients with stage 3 or stage 4 chronic kidney disease and patients with stage 5 chronic kidney disease on dialysis.
|
| Mozobil®
Mozobil (plerixafor injection), is indicated for use in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma.
|
| Myozyme®
Myozyme (alglucosidase alfa) is an enzyme replacement therapy for Pompe disease.
|
| Renagel®
Renagel (sevelamer hydrochloride) is a calcium-free, metal-free phosphate binder that controls serum phosphorus levels in patients with chronic kidney disease on hemodialysis.
|
| Renvela®
Renvela (sevelamer carbonate)is a next-generation version of Renagel® (sevelamer hydrochloride), the most-prescribed phosphate binder in the United States.
|
| Seprafilm®
Seprafilm is a temporary, physical adhesion barrier for abdominal and pelvic adhesion prevention.
|
| SynviscOne™
Synvisc-One™ (hylan G-F 20) and SYNVISC® (hylan G-F 20) are used to relieve knee pain due to osteoarthritis (OA). They are for patients who do not get enough relief from simple painkillers such as acetaminophen, or from exercise and physical therapy.
|
| Thymoglobulin®
Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] is an immunosuppressive polyclonal antibody that is used in conjunction with concomitant immunosuppression to treat acute rejection in kidney transplant patients.
|
| Thyrogen®
Thyrogen (thyrotropin alfa for injection) is an adjunctive diagnostic used in follow-up screenings of cancer patients with well-differentiated thyroid cancer who have had their thyroid glands removed. |
Genzyme Product Sites for EU Audiences
Genzyme Disease Education/Research/Support Sites
| Renassist
|
Genzyme International Subsidiaries Sites
Home
Genzyme Websites
